News
Johnson & Johnson is closing down its pharma division’s cardiovascular and metabolic unit.
Johnson & Johnson is shutting down its pharma division’s cardiovascular and metabolic unit, marking at least the second large restructuring for the pharma group following the closure of its infectious disease and vaccine unit last year
The change primarily impacts the sales, marketing and medical affairs teams, who have been notified.
Type: industry
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins